Viamet Pharmaceuticals Inc., a Research Triangle Park, N.C.-based biotech company targeting metalloenzymes, has raised $4 million in Series A funding. Hatteras Venture Partners and seed backer Intersouth Partners co-led the deal. www.viamet.com
Viamet Pharmaceuticals Inc., a Research Triangle Park, N.C.-based biotech company targeting metalloenzymes, has raised $4 million in Series A funding. Hatteras Venture Partners and seed backer Intersouth Partners co-led the deal. www.viamet.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.